Finance

Lists
300760:SHE
Shenzhen Mindray Bio-Medl Elctrnc Co Ltd
CN¥164,55
-0,24%
(-0,39) 1D
14 Okt., 15:04:46 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300760...
Open
CN¥164,30
High
CN¥166,28
Low
CN¥163,58
Mkt. cap
199,87 mjd
Avg. vol.
7,72 m
Volume
5,03 m
Dividend
2,58%
Quarterly dividend
CN¥1,06
Ex-dividend date
08 Sep. 2026
P/E ratio
25,37
52-wk high
CN¥239,79
52-wk low
CN¥130,66
EPS
CN¥6,49
Shares outstanding
1,21 mjd
No. of employees
21 k
Open
CN¥164,30
High
CN¥166,28
Low
CN¥163,58
Mkt. cap
199,87 mjd
Avg. vol.
7,72 m
Volume
5,03 m
Dividend
2,58%
Quarterly dividend
CN¥1,06
Ex-dividend date
08 Sep. 2026
P/E ratio
25,37
52-wk high
CN¥239,79
52-wk low
CN¥130,66
EPS
CN¥6,49
Shares outstanding
1,21 mjd
No. of employees
21 k
News stories
From web sources and news partners
Profile
Mindray Bio-Medical Electronics Co., Ltd., simply known as Mindray, is a Chinese multinational health technology company based in Shenzhen, Guangdong. Mindray designs and produces medical equipment and accessories for both human and veterinary use. The company is organized into three key business lines: Patient Monitoring & Life Support, In-Vitro Diagnostic Products, and Medical Imaging Systems. In 2008, Mindray was recognized as China's largest medical device manufacturer. Wikipedia
About Shenzhen Mindray Bio-Medl Elctrnc Co Ltd
CEO-
Employees21,3 k
Founded1991
Headquarters-
SectorMedical device
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
9,09 mjd
7,45 mjd
8,35 mjd
9,39 mjd
Cost of goods sold
3,32 mjd
3,70 mjd
3,18 mjd
3,83 mjd
Cost of revenue
3,32 mjd
3,70 mjd
3,18 mjd
3,83 mjd
Research and development expenses
828,27 m
1,14 mjd
801,74 m
767,77 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,68 mjd
1,91 mjd
1,58 mjd
1,63 mjd
Operating expense
2,53 mjd
3,19 mjd
2,39 mjd
2,44 mjd
Total operating expenses
5,85 mjd
6,89 mjd
5,57 mjd
6,27 mjd
Operating income
3,24 mjd
563,02 m
2,78 mjd
3,12 mjd
Other non operating income
-38,60 m
13,79 m
-332,20 m
288,46 m
EBT including unusual items
2,98 mjd
772,35 m
2,54 mjd
3,01 mjd
EBT excluding unusual items
3,16 mjd
581,57 m
2,57 mjd
2,97 mjd
Income tax expense
403,50 m
134,78 m
114,81 m
394,38 m
Effective tax rate
13,52%
17,45%
4,52%
13,08%
Other operating expenses
-8,48 m
90,41 m
-9,50 m
47,65 m
Net income
2,50 mjd
565,73 m
2,33 mjd
2,47 mjd
Net profit margin
27,51%
7,60%
27,89%
26,26%
Earnings per share
2,07
-
-
-
Interest and investment income
132,38 m
125,46 m
124,39 m
141,61 m
Interest expense
-6,45 m
-7,27 m
-6,07 m
-5,92 m
Net interest expenses
125,93 m
118,19 m
118,32 m
135,69 m
Depreciation and amortization charges
-
-
-
-
EBITDA
3,57 mjd
951,35 m
3,17 mjd
3,55 mjd
Gain or loss from assets sale
736,57 k
-10,72 m
-
9,02 m
AI content may include mistakes. Learn more
Google-programme